-
1
-
-
0026050590
-
Epidemiology and pathogenesis of systemic fungal infection in the immunocompromised host
-
Denning, D.W. Epidemiology and pathogenesis of systemic fungal infection in the immunocompromised host. J Antimicrob Chemother 1991, 28 (Suppl. B): 1-16.
-
(1991)
J Antimicrob Chemother
, vol.28
, Issue.SUPPL. B
, pp. 1-16
-
-
Denning, D.W.1
-
2
-
-
0025256091
-
Amphotericin B. 30 Years of clinical experience
-
Gallis, H.A., Drew, R.H., Pickarrd, W.W. Amphotericin B. 30 years of clinical experience. Rev Infect Dis 1990, 12: 308-29.
-
(1990)
Rev Infect Dis
, vol.12
, pp. 308-329
-
-
Gallis, H.A.1
Drew, R.H.2
Pickarrd, W.W.3
-
3
-
-
0027960239
-
Visceral leishmaniasis is more prevalent and more problematic
-
Baily, G.G., Nandy, A. Visceral leishmaniasis is more prevalent and more problematic. J Infect 1994, 29: 241-7.
-
(1994)
J Infect
, vol.29
, pp. 241-247
-
-
Baily, G.G.1
Nandy, A.2
-
4
-
-
0025953653
-
Liposmal amphotericin B in the treatment of visceral (Leishmaniasis)
-
Croft, S.L., Davidson, R.N., Thornton, E.A. Liposmal amphotericin B in the treatment of visceral (Leishmaniasis). J Antimicrob Agents 1991, 28 (Suppl. B): 111-8.
-
(1991)
J Antimicrob Agents
, vol.28
, Issue.SUPPL. B
, pp. 111-118
-
-
Croft, S.L.1
Davidson, R.N.2
Thornton, E.A.3
-
5
-
-
0030706106
-
Aspergillus and candida infections in bone marrow transplantation: Progress and controversies
-
Revankar, S.G., Patterson, T.F. Aspergillus and candida infections in bone marrow transplantation: Progress and controversies. Infect Dis Clin Pract 1997, 6: 506-12.
-
(1997)
Infect Dis Clin Pract
, vol.6
, pp. 506-512
-
-
Revankar, S.G.1
Patterson, T.F.2
-
6
-
-
0028919545
-
Pretreatment regimens for adverse events related to infusion of amphotericin B
-
Goodwin, S.D., Cleary, J.D., Walawander, C.A. et al. Pretreatment regimens for adverse events related to infusion of amphotericin B. Clinical Infect Dis 1995, 20: 755-61.
-
(1995)
Clinical Infect Dis
, vol.20
, pp. 755-761
-
-
Goodwin, S.D.1
Cleary, J.D.2
Walawander, C.A.3
-
7
-
-
0033376314
-
Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
-
Windgard, J.R., Kubilis, P., Lee, L. et al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis 1999, 29: 1402-7.
-
(1999)
Clin Infect Dis
, vol.29
, pp. 1402-1407
-
-
Windgard, J.R.1
Kubilis, P.2
Lee, L.3
-
8
-
-
0346649983
-
Mechanism of action of an anti-candida drug: Amphotericin B and its derivatives
-
Prasad, R. (Ed.) Springer-Verlag KB, Berlin
-
Bolard, J. Mechanism of action of an anti-candida drug: amphotericin B and its derivatives. In: Candida albicans. Cellular and molecular biology. Prasad, R. (Ed.) Springer-Verlag KB, Berlin 1991, 213-38.
-
(1991)
Candida Albicans. Cellular and Molecular Biology
, pp. 213-238
-
-
Bolard, J.1
-
9
-
-
0011373188
-
Amphotericin B derivatives
-
Fromtling, R.A. (Ed.) J.R. Prous, Barcelona, Spain
-
Schaffner, C.P. Amphotericin B derivatives. In: Recent trends in the discovery, development and evaluation of antifungal agents. Fromtling, R.A. (Ed.) J.R. Prous, Barcelona, Spain 1987, 595-610.
-
(1987)
Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents
, pp. 595-610
-
-
Schaffner, C.P.1
-
10
-
-
0026677494
-
Liposomes: Realizing their promise
-
Bangham, A.D. Liposomes: realizing their promise. Hosp Pract 1992, 27: 51-62.
-
(1992)
Hosp Pract
, vol.27
, pp. 51-62
-
-
Bangham, A.D.1
-
11
-
-
0028356893
-
Clinical use of liposomal and lipid-complexed amphotericin B
-
De Marie, S., Janknegt R., Bakker-Wouden Berg, I.A.J. Clinical use of liposomal and lipid-complexed amphotericin B. J Antimicrob Chemother 1994, 33: 907-16.
-
(1994)
J Antimicrob Chemother
, vol.33
, pp. 907-916
-
-
De Marie, S.1
Janknegt, R.2
Bakker-Wouden Berg, I.A.J.3
-
12
-
-
0028954312
-
Amphotericin B lipid complex
-
Fromtling, R.A. Amphotericin B lipid complex. Drugs Fut 1995, 20: 129-34.
-
(1995)
Drugs Fut
, vol.20
, pp. 129-134
-
-
Fromtling, R.A.1
-
13
-
-
0027314254
-
Amphotericin B its delivery by liposomal and lipid formulation
-
Gates, C., Pinney, R.J. Amphotericin B and its delivery by liposomal and lipid formulation. J Clin Pharm Ther 1993, 18: 147-53.
-
(1993)
J Clin Pharm Ther
, vol.18
, pp. 147-153
-
-
Gates, C.1
Pinney, R.J.2
-
14
-
-
0028308848
-
Liposomal amphotericin B, AmBisome
-
Hay, R.J. Liposomal amphotericin B, AmBisome. J Infect 1994, 28 (Suppl. 1): 35-43.
-
(1994)
J Infect
, vol.28
, Issue.SUPPL. 1
, pp. 35-43
-
-
Hay, R.J.1
-
15
-
-
0028343094
-
Alternative modalities of administering amphotericin B: Current issues
-
Meunier, F. Alternative modalities of administering amphotericin B: Current issues. J Infect 1994, 28 (Suppl. 1): 51-6.
-
(1994)
J Infect
, vol.28
, Issue.SUPPL. 1
, pp. 51-56
-
-
Meunier, F.1
-
16
-
-
0026437668
-
Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes
-
Legrand, P., Romero, E.A., Cohers, B.E., Bolard, J. Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrob Agents Chemother 1992, 36: 2518-22.
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 2518-2522
-
-
Legrand, P.1
Romero, E.A.2
Cohers, B.E.3
Bolard, J.4
-
17
-
-
0025808089
-
One-sided action of amphotericin B on cholesterol containing membranes is determined by its self association in the medium
-
Bolard, J., Legrand, P., Heitz, F., Cybulska, B. One-sided action of amphotericin B on cholesterol containing membranes is determined by its self association in the medium. Biochemistry 1991, 30: 5707-15.
-
(1991)
Biochemistry
, vol.30
, pp. 5707-5715
-
-
Bolard, J.1
Legrand, P.2
Heitz, F.3
Cybulska, B.4
-
18
-
-
0023554369
-
The effect of azole and polyene antifungals on the plasma membrane enzymes of candida albicans
-
Surarit, R., Stepherd, M.G. The effect of azole and polyene antifungals on the plasma membrane enzymes of candida albicans. J Med Vet Mycol 1987, 25: 403-9.
-
(1987)
J Med Vet Mycol
, vol.25
, pp. 403-409
-
-
Surarit, R.1
Stepherd, M.G.2
-
20
-
-
0020353723
-
Association of the polyene antibiotic amphotericin B with phospholipid vesicles: Perturbation by temperature changes
-
Bolard, J., Cheron, M. Association of the polyene antibiotic amphotericin B with phospholipid vesicles: Perturbation by temperature changes. Can J Biochem 1982, 60: 782-9.
-
(1982)
Can J Biochem
, vol.60
, pp. 782-789
-
-
Bolard, J.1
Cheron, M.2
-
21
-
-
0021821734
-
Effect of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits
-
Koldin, M.H., Kohayashi, G.S., Brajtburg, J., Medoff, G. Effect of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits. Antimicrob Agents chemother 1985, 28: 144-5.
-
(1985)
Antimicrob Agents Chemother
, vol.28
, pp. 144-145
-
-
Koldin, M.H.1
Kohayashi, G.S.2
Brajtburg, J.3
Medoff, G.4
-
22
-
-
0026355895
-
Inhibition of the interaction between lipoproteins and amphotericin B by some delivery systems
-
Barwicz, J., Gareau, R., Audet, A., Morisset, A., Villiard, J., Gruda, I. Inhibition of the interaction between lipoproteins and amphotericin B by some delivery systems. Biochem Biophys Res Commun 1991, 181: 722-8.
-
(1991)
Biochem Biophys Res Commun
, vol.181
, pp. 722-728
-
-
Barwicz, J.1
Gareau, R.2
Audet, A.3
Morisset, A.4
Villiard, J.5
Gruda, I.6
-
23
-
-
0021686735
-
Enhancement of amphotericin B selectively by antibiotic incorporation into gel state vesicles. A circular dichroism and permeability study
-
Vertut-Croquin, A., Bolord, J., Gary-Bobo, C. Enhancement of amphotericin B selectively by antibiotic incorporation into gel state vesicles. A circular dichroism and permeability study. Biochem Biophys Res Commun 1984, 125: 360-5.
-
(1984)
Biochem Biophys Res Commun
, vol.125
, pp. 360-365
-
-
Vertut-Croquin, A.1
Bolord, J.2
Gary-Bobo, C.3
-
24
-
-
0021847339
-
Transfer of amphotericin B from gel state vesicles to mycoplasma cells: Biphasic action on potassium transport and permeability
-
Vertut-Croquin, A., Bolord, A., Gary-Bobo, C. Transfer of amphotericin B from gel state vesicles to mycoplasma cells: Biphasic action on potassium transport and permeability. Antimicrob Agents Chemother 1985, 28: 167-71.
-
(1985)
Antimicrob Agents Chemother
, vol.28
, pp. 167-171
-
-
Vertut-Croquin, A.1
Bolord, A.2
Gary-Bobo, C.3
-
25
-
-
0018881828
-
Comparative properties and methods of preparations of lipid vesicles (liposomes)
-
Szoka, F. Jr., Papahadjopoulos, D. Comparative properties and methods of preparations of lipid vesicles (liposomes). Ann Rev Biophys Bioengineer 1980, 9: 457-508.
-
(1980)
Ann Rev Biophys Bioengineer
, vol.9
, pp. 457-508
-
-
Szoka Jr., F.1
Papahadjopoulos, D.2
-
26
-
-
0015795402
-
Phase transitions in phospholipid vesicles. Florescence polarization and permeability measurements concerning the effect of temperature and cholesterol
-
Papahadjopoulos, D., Jacobson, K., Nir, S., Isac, T. Phase transitions in phospholipid vesicles. Florescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim Biophys Act 1973, 311: 330-48.
-
(1973)
Biochim Biophys Act
, vol.311
, pp. 330-348
-
-
Papahadjopoulos, D.1
Jacobson, K.2
Nir, S.3
Isac, T.4
-
27
-
-
0022862167
-
How do the polyene macrolide antibiotics affect the cellular membrane properties?
-
Bolard, J. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophy Acta 1986, 864: 257-304.
-
(1986)
Biochim Biophy Acta
, vol.864
, pp. 257-304
-
-
Bolard, J.1
-
28
-
-
0022439033
-
Mode of action of clinically important antifungal drugs
-
Kerridge, D. Mode of action of clinically important antifungal drugs. Adv Microb Physiol 1986, 27: 1-72.
-
(1986)
Adv Microb Physiol
, vol.27
, pp. 1-72
-
-
Kerridge, D.1
-
29
-
-
0021750223
-
Effect of surface curvature on the interaction of single lamellar phospholipid vesicles with aromatic and non aromatic heptane antibiotics
-
Bolard, J., Cheron, M., Mazer Ski, J. Effect of surface curvature on the interaction of single lamellar phospholipid vesicles with aromatic and non aromatic heptane antibiotics. Biochem Pharmacol 1984, 33: 3675-80.
-
(1984)
Biochem Pharmacol
, vol.33
, pp. 3675-3680
-
-
Bolard, J.1
Cheron, M.2
Mazer Ski, J.3
-
30
-
-
0025974347
-
Phase behaviour of amphotericin B multilamellar vesicles
-
Hamilton, K.S., Barber, K.R., Davis, J.H., Neal, K., Grant, C.W.M. Phase behaviour of amphotericin B multilamellar vesicles. Biochim Biophys Acta 1991, 1062: 220-6.
-
(1991)
Biochim Biophys Acta
, vol.1062
, pp. 220-226
-
-
Hamilton, K.S.1
Barber, K.R.2
Davis, J.H.3
Neal, K.4
Grant, C.W.M.5
-
31
-
-
0024374196
-
Physical biochemistry of a liposomal amphotericin B mixture used for patient treatment
-
Grant, C.W.M., Hamilton, K.S., Hamilton, K.D., Barber, K.R. Physical biochemistry of a liposomal amphotericin B mixture used for patient treatment. Biochim Biophys Acta 1989, 984: 11-20.
-
(1989)
Biochim Biophys Acta
, vol.984
, pp. 11-20
-
-
Grant, C.W.M.1
Hamilton, K.S.2
Hamilton, K.D.3
Barber, K.R.4
-
32
-
-
0021268461
-
Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice
-
Lopez-Berestein, G., Hopfer, R.L., Mehta, R., Mehta, K., Hersh, E.M., Juliano, R.L. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis 1984, 150: 278-83.
-
(1984)
J Infect Dis
, vol.150
, pp. 278-283
-
-
Lopez-Berestein, G.1
Hopfer, R.L.2
Mehta, R.3
Mehta, K.4
Hersh, E.M.5
Juliano, R.L.6
-
33
-
-
0021958862
-
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study
-
Lopez-Berestein, G., Fainstein, V., Hopfer, R. et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study. J Infect Dis 1985, 151: 704-10.
-
(1985)
J Infect Dis
, vol.151
, pp. 704-710
-
-
Lopez-Berestein, G.1
Fainstein, V.2
Hopfer, R.3
-
34
-
-
0023157745
-
Treatment of nepatosplenic candidiasis with liposomal - Amphotericin B
-
Lopez-Berestein, G., Bodey, G.P., Frankel, L.S., Mehta, K. Treatment of nepatosplenic candidiasis with liposomal - Amphotericin B. J Clin Oncol 1987, 5: 310-7.
-
(1987)
J Clin Oncol
, vol.5
, pp. 310-317
-
-
Lopez-Berestein, G.1
Bodey, G.P.2
Frankel, L.S.3
Mehta, K.4
-
35
-
-
0027316810
-
Clinical experience with multilamellar liposomal amphotericin B in patients with proven and suspected fungal infection
-
Ralph, E.D., Barber, K.R., Grant, C.W.M. Clinical experience with multilamellar liposomal amphotericin B in patients with proven and suspected fungal infection. Scand J Infect Dis 1993, 23: 487-96.
-
(1993)
Scand J Infect Dis
, vol.23
, pp. 487-496
-
-
Ralph, E.D.1
Barber, K.R.2
Grant, C.W.M.3
-
36
-
-
0024592238
-
Interaction of the polyene antibiotic amphotericin B with model membranes: Differences between small and large unilamellar vesicles
-
Milhaud, J., Hartmann, M.A., Bolard, J. Interaction of the polyene antibiotic amphotericin B with model membranes: Differences between small and large unilamellar vesicles. Biochimie 1989, 71: 49-56.
-
(1989)
Biochimie
, vol.71
, pp. 49-56
-
-
Milhaud, J.1
Hartmann, M.A.2
Bolard, J.3
-
37
-
-
0024160529
-
Amphotericin B encapsulated in liposomes administered to cancer patients
-
Meunier, F., Sculier, J.P., Coune, A. et al. Amphotericin B encapsulated in liposomes administered to cancer patients. Ann NY Acad Sci 1988, 544: 598-610.
-
(1988)
Ann NY Acad Sci
, vol.544
, pp. 598-610
-
-
Meunier, F.1
Sculier, J.P.2
Coune, A.3
-
38
-
-
0024421096
-
Pharmacokinetics of amphotericin B in patients receiving repeated intravenous high doses of amphotericin B entrapped into sonicated liposomes
-
Sculier, J.P., Delcroix, C., Brassinne, C., Laduron, C., Hollaert, C. Pharmacokinetics of amphotericin B in patients receiving repeated intravenous high doses of amphotericin B entrapped into sonicated liposomes. J Liposome Res 1989, 1: 151-66.
-
(1989)
J Liposome Res
, vol.1
, pp. 151-166
-
-
Sculier, J.P.1
Delcroix, C.2
Brassinne, C.3
Laduron, C.4
Hollaert, C.5
-
39
-
-
0025259609
-
In-vitro evaluation of the antifungal activity of amphotericin B entrapped into liposomes during storage for one year
-
Heymans, C., Vander Auwera, P., Scalier, J.P. et al. In-vitro evaluation of the antifungal activity of amphotericin B entrapped into liposomes during storage for one year. J Antimicrob Chemother 1990, 25: 361-6.
-
(1990)
J Antimicrob Chemother
, vol.25
, pp. 361-366
-
-
Heymans, C.1
Vander Auwera, P.2
Scalier, J.P.3
-
40
-
-
0027324048
-
Successful treatment of disseminated candidiasis resistant to amphotericin B by liposonal amphotericin B: A case report
-
Gokhale, P., Barapatre, R.J., Advani, S.H., Kshirsagar, N.A., Bandya, S.K. Successful treatment of disseminated candidiasis resistant to amphotericin B by liposonal amphotericin B: A case report. J Cancer Res Clin Oncol 1993, 119: 569-71.
-
(1993)
J Cancer Res Clin Oncol
, vol.119
, pp. 569-571
-
-
Gokhale, P.1
Barapatre, R.J.2
Advani, S.H.3
Kshirsagar, N.A.4
Bandya, S.K.5
-
41
-
-
0038548568
-
Management of Aspergillus osteomylitis: Report of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review
-
Stratov, I., Korman, T.M., Johnson, P.D. Management of Aspergillus osteomylitis: Report of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis 2003, 22: 277-83.
-
(2003)
Eur J Clin Microbiol Infect Dis
, vol.22
, pp. 277-283
-
-
Stratov, I.1
Korman, T.M.2
Johnson, P.D.3
-
42
-
-
0036560408
-
Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection
-
Bodne, P.V., Kotwani, R.N., Kirodian, B.G., Kshirsagar, N.A., Pandya, S.K. Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. J Assoc Physicians India 2002, 50: 662-70.
-
(2002)
J Assoc Physicians India
, vol.50
, pp. 662-670
-
-
Bodne, P.V.1
Kotwani, R.N.2
Kirodian, B.G.3
Kshirsagar, N.A.4
Pandya, S.K.5
-
43
-
-
0036234824
-
Drug delivery system of anti-fungal and parasitic agents
-
Maesaki, S. Drug delivery system of anti-fungal and parasitic agents. Curr Pharm Des 2002, 8: 433-40.
-
(2002)
Curr Pharm Des
, vol.8
, pp. 433-440
-
-
Maesaki, S.1
-
44
-
-
0019324697
-
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro
-
Kirby, C., Clarke, J., Gregariadis, G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 1980, 186: 591-8.
-
(1980)
Biochem J
, vol.186
, pp. 591-598
-
-
Kirby, C.1
Clarke, J.2
Gregariadis, G.3
-
45
-
-
0030933186
-
The formation of amphotericin B ion channels in lipid bilayers
-
Fujii, G., Chang, J.E., Coley, T., Sreere, B. The formation of amphotericin B ion channels in lipid bilayers. Biochemistry 1997, 38: 4959-68.
-
(1997)
Biochemistry
, vol.38
, pp. 4959-4968
-
-
Fujii, G.1
Chang, J.E.2
Coley, T.3
Sreere, B.4
-
46
-
-
0029145597
-
Liposomal antifungal battle for market share
-
Glasser, V. Liposomal antifungal battle for market share. BioTechnology 1995, 13: 728-9.
-
(1995)
BioTechnology
, vol.13
, pp. 728-729
-
-
Glasser, V.1
-
47
-
-
7844233666
-
Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia Associated invasive fungal infections
-
Alexander, C., Leenders, A.P., Simon Daener et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia Associated invasive fungal infections. Brit J Haematol 1998, 103: 205-12.
-
(1998)
Brit J Haematol
, vol.103
, pp. 205-212
-
-
Alexander, C.1
Leenders, A.P.2
Daener, S.3
-
48
-
-
0027139351
-
Development, characterization, efficacy and mode of action of AmBiosome, a unilamellar liposomal formulation of amphotericin B
-
Adler-Moore, J.P., Proffitt, R.J. Development, characterization, efficacy and mode of action of AmBiosome, a unilamellar liposomal formulation of amphotericin B. J Liposome Res 1993, 393: 429-50.
-
(1993)
J Liposome Res
, vol.393
, pp. 429-450
-
-
Adler-Moore, J.P.1
Proffitt, R.J.2
-
49
-
-
0027980052
-
Liposomal amphotericin B (AmBisome) in mediterranean visceral leishmaniasis. A multicentre trial
-
Davidson, R.N., Dimartino, L., Gradoni, L. et al. Liposomal amphotericin B (AmBisome) in mediterranean visceral leishmaniasis. A multicentre trial. Q J Med 1994, 87: 75-81.
-
(1994)
Q J Med
, vol.87
, pp. 75-81
-
-
Davidson, R.N.1
Dimartino, L.2
Gradoni, L.3
-
50
-
-
0036178457
-
AmBisome: Liposomal formulation, structure, mechanism of action and preclinical experience
-
Moore, A., Proffit, R.T. AmBisome: Liposomal formulation, structure, mechanism of action and preclinical experience. J Antimicrob Chemother 2002, 49 (Suppl. 1): 21-30.
-
(2002)
J Antimicrob Chemother
, vol.49
, Issue.SUPPL. 1
, pp. 21-30
-
-
Moore, A.1
Proffit, R.T.2
-
51
-
-
0001571784
-
Usual lipid structures selectively reduce the toxicity of amphetericin B
-
Janoff, A.S., Boni, L.J., Poescu, M.C. et al. Usual lipid structures selectively reduce the toxicity of amphetericin B. Proc Natl Acad Sci USA 1988, 85: 6122-6.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 6122-6126
-
-
Janoff, A.S.1
Boni, L.J.2
Poescu, M.C.3
-
52
-
-
17344368128
-
Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
-
Walsh, T.J., Hiemenz, J.W., Seibel, N.L. et al. Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998, 26: 1383-96.
-
(1998)
Clin Infect Dis
, vol.26
, pp. 1383-1396
-
-
Walsh, T.J.1
Hiemenz, J.W.2
Seibel, N.L.3
-
53
-
-
0001213695
-
Amphotericin B lipid complex versus amphotericin B for the treatment of hematogenous and invasive candidiasis: A prospective ramdomized multicentre trial
-
San Francisco
-
Anaissie, E.J., White, M., Uzun, O. et al. Amphotericin B lipid complex versus amphotericin B for the treatment of hematogenous and invasive candidiasis: A prospective ramdomized multicentre trial. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco 1995, 330: 17-20.
-
(1995)
Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy
, vol.330
, pp. 17-20
-
-
Anaissie, E.J.1
White, M.2
Uzun, O.3
-
54
-
-
9044250097
-
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcol meningitis in patients with AIDS
-
Sharkey, P.K., Graybill, J.R., Johnson, E.S. et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcol meningitis in patients with AIDS. Clin Infect Dis 1996, 22: 315-21.
-
(1996)
Clin Infect Dis
, vol.22
, pp. 315-321
-
-
Sharkey, P.K.1
Graybill, J.R.2
Johnson, E.S.3
-
55
-
-
0028954312
-
Amphotericin B lipid complex
-
Fromtling, R.A. Amphotericin B lipid complex. Drugs Fut 1995, 20: 129-34.
-
(1995)
Drugs Fut
, vol.20
, pp. 129-134
-
-
Fromtling, R.A.1
-
56
-
-
0023137231
-
Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposomal intercalated amphotericin B
-
Szoka, F.C., Miltrolland, D., Barza, M. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposomal intercalated amphotericin B. Antimicrob Agents Chemother 1987, 31: 421-9.
-
(1987)
Antimicrob Agents Chemother
, vol.31
, pp. 421-429
-
-
Szoka, F.C.1
Miltrolland, D.2
Barza, M.3
-
57
-
-
0028283641
-
Overview of amphotericin B colloidal dispersion (Amphocil)
-
Stevens, D.A. Overview of amphotericin B colloidal dispersion (Amphocil). J Infact 1994, 28 (Suppl. 1) 45-9.
-
(1994)
J Infact
, vol.28
, Issue.SUPPL. 1
, pp. 45-49
-
-
Stevens, D.A.1
-
58
-
-
0033032842
-
Safety and efficacy of amphotericin B colloidal dispersion. An overview
-
Herbrecht, R., Letscher, V., Andres, E., Cavalier, A. Safety and efficacy of amphotericin B colloidal dispersion. An overview. Chemotherapy 1999, 45: 67-76.
-
(1999)
Chemotherapy
, vol.45
, pp. 67-76
-
-
Herbrecht, R.1
Letscher, V.2
Andres, E.3
Cavalier, A.4
-
59
-
-
0001276697
-
Zygomycosis treated with amphotericin B colloidal dispersion. A review of 22 cases
-
Herbrecht, R., Letscher, V., Andres, E., Kusne, S., Gurwith, M., Oberling, F. Zygomycosis treated with amphotericin B colloidal dispersion. A review of 22 cases. Blood 1996, 88: 502a.
-
(1996)
Blood
, vol.88
-
-
Herbrecht, R.1
Letscher, V.2
Andres, E.3
Kusne, S.4
Gurwith, M.5
Oberling, F.6
-
61
-
-
7344264567
-
Ramdomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
-
White, M.H., Bowden, R.A., Sandler, E.S. et al. Ramdomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia. Clin Infect Dis 1998, 27: 296-302.
-
(1998)
Clin Infect Dis
, vol.27
, pp. 296-302
-
-
White, M.H.1
Bowden, R.A.2
Sandler, E.S.3
-
62
-
-
0029115636
-
Population pharmacokinetics and renal function, sparing effects of amphotericin B in colloidal dispersion in patients receiving bone marrow transplants
-
Amantea, M.A., Bowden, R.A., Forest, A., Working P.K., Newman, M.S., Mamclok, R.D. Population pharmacokinetics and renal function, sparing effects of amphotericin B in colloidal dispersion in patients receiving bone marrow transplants. Antimicrob Agents Chemother 1995, 39: 2042-7.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 2042-2047
-
-
Amantea, M.A.1
Bowden, R.A.2
Forest, A.3
Working, P.K.4
Newman, M.S.5
Mamclok, R.D.6
-
63
-
-
0027288083
-
Amphotericin B cholesterol sulfate complex (colloidal dispersion)
-
Fromting, R.A. Amphotericin B, cholesterol sulfate complex (colloidal dispersion). Drugs Fut 1993, 18: 303-6.
-
(1993)
Drugs Fut
, vol.18
, pp. 303-306
-
-
Fromting, R.A.1
-
64
-
-
0023743895
-
An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis
-
Krish, R., Goldstein, R., Tarloff, J. et al. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis 1988, 158: 1065-70.
-
(1988)
J Infect Dis
, vol.158
, pp. 1065-1070
-
-
Krish, R.1
Goldstein, R.2
Tarloff, J.3
-
65
-
-
0028123632
-
In vitro renal toxicity and in-vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid
-
Joly, V., Farinotti, R., Saint Julien, L., Cheron, M., Carbon, C., Yeni, P. In vitro renal toxicity and in-vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid. Antimicrob Agents Chemother 1994, 38: 177-83.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 177-183
-
-
Joly, V.1
Farinotti, R.2
Saint Julien, L.3
Cheron, M.4
Carbon, C.5
Yeni, P.6
-
66
-
-
0027478044
-
Effficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients
-
Caillot, D., Casasnovas, O., Solary, E. et al. Effficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients. J Antimicrob Chemother 1993, 31: 161-9.
-
(1993)
J Antimicrob Chemother
, vol.31
, pp. 161-169
-
-
Caillot, D.1
Casasnovas, O.2
Solary, E.3
-
67
-
-
0026658704
-
Clinical evaluation of a new lipid based delivery system for intravenous administration of amphotericin B
-
Caillot, D., Charanet, R., Casasnovas, O. et al. Clinical evaluation of a new lipid based delivery system for intravenous administration of amphotericin B. Eur J Clin Microbiol Infect Dis 1992, 11: 722-5.
-
(1992)
Eur J Clin Microbiol Infect Dis
, vol.11
, pp. 722-725
-
-
Caillot, D.1
Charanet, R.2
Casasnovas, O.3
-
68
-
-
0026452250
-
Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutropenic patients
-
Moreau, P., Milpied, N., Fayette, N., Ramee, J.F., Harousseau, J.L. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutropenic patients. J Antimicrob Chemother 1992, 30: 535-41.
-
(1992)
J Antimicrob Chemother
, vol.30
, pp. 535-541
-
-
Moreau, P.1
Milpied, N.2
Fayette, N.3
Ramee, J.F.4
Harousseau, J.L.5
-
69
-
-
0027297766
-
Toxicity of amphotericin B emulsion formulations
-
Washington, C., Lance, M., Davis, S.S. Toxicity of amphotericin B emulsion formulations. J Antimicrob Chemother 1993, 31: 806-8.
-
(1993)
J Antimicrob Chemother
, vol.31
, pp. 806-808
-
-
Washington, C.1
Lance, M.2
Davis, S.S.3
-
70
-
-
0033895538
-
Attentuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B
-
Hossain, M.A., Maesaki, S., Razzaque, M.S., Tomono, K., Taguchi, T., Kohno, S. Attentuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B. J Antimicrob Chemother 2000, 46: 263-8.
-
(2000)
J Antimicrob Chemother
, vol.46
, pp. 263-268
-
-
Hossain, M.A.1
Maesaki, S.2
Razzaque, M.S.3
Tomono, K.4
Taguchi, T.5
Kohno, S.6
-
71
-
-
0037373019
-
-
Syriopoulou, V., Daikos, G.L., Theodoridou, M. et al. Clin Infect Dis 2003, 36: 560-6.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 560-566
-
-
Syriopoulou, V.1
Daikos, G.L.2
Theodoridou, M.3
-
72
-
-
0036241196
-
Lipid formulation as a drug carrier for drug delivery
-
Tomii, Y. Lipid formulation as a drug carrier for drug delivery. Curr Pharm Des 2002, 8: 467-74.
-
(2002)
Curr Pharm Des
, vol.8
, pp. 467-474
-
-
Tomii, Y.1
-
73
-
-
0036282364
-
-
Brime, B., Moreno, M.A., Frutos, G., Ballesteros, M.P., Frutos, P.J. Pharm Sci 2002, 91: 1178-85.
-
(2002)
Pharm Sci
, vol.91
, pp. 1178-1185
-
-
Brime, B.1
Moreno, M.A.2
Frutos, G.3
Ballesteros, M.P.4
Frutos, P.J.5
-
75
-
-
0028353627
-
Administering amphotericin B - A practical approach
-
Khoo, S.H., Bond, J., Denning, D.W. Administering amphotericin B - A practical approach. J Antimicrob Chemother 1994, 33: 203-13.
-
(1994)
J Antimicrob Chemother
, vol.33
, pp. 203-213
-
-
Khoo, S.H.1
Bond, J.2
Denning, D.W.3
-
76
-
-
0020663457
-
Clinical pharmacokinetics of systemic antifungal drugs
-
Daneshmend, T.K., Warnock, D.W. Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet 1983, 8: 17-42.
-
(1983)
Clin Pharmacokinet
, vol.8
, pp. 17-42
-
-
Daneshmend, T.K.1
Warnock, D.W.2
-
77
-
-
0025877789
-
Amphotericin B lipid complex therapy of experimental fungal infections in mice
-
Clark, J.M., Whitney, R.R., Olsen, S.J. et al. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother 1991, 35: 615-21.
-
(1991)
Antimicrob Agents Chemother
, vol.35
, pp. 615-621
-
-
Clark, J.M.1
Whitney, R.R.2
Olsen, S.J.3
-
78
-
-
0026043820
-
Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents
-
Proffitt, R.T., Satorius, A., Chiang, S.M., Sullivan, L., Adler-Moore, J.P. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 1991, 28 (Suppl. B): 49-61.
-
(1991)
J Antimicrob Chemother
, vol.28
, Issue.SUPPL. B
, pp. 49-61
-
-
Proffitt, R.T.1
Satorius, A.2
Chiang, S.M.3
Sullivan, L.4
Adler-Moore, J.P.5
-
79
-
-
0028266748
-
Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits
-
Lee, J.W., Amantea, M.A., Francis, A. et al. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrob Agents Chemother 1994, 38: 113-8.
-
(1994)
Antimicrob Agents Chemother
, vol.38
, pp. 113-118
-
-
Lee, J.W.1
Amantea, M.A.2
Francis, A.3
-
80
-
-
0025300339
-
Liposomal amphotericin B (AmBisome) treatment in solid organ and bone marrow transplant recipients: Efficacy and safety evaluation
-
Tollernar, J., Ringden, O., Tyden, G. Liposomal amphotericin B (AmBisome) treatment in solid organ and bone marrow transplant recipients: Efficacy and safety evaluation. Clin Transplant 1990, 4: 167-75.
-
(1990)
Clin Transplant
, vol.4
, pp. 167-175
-
-
Tollernar, J.1
Ringden, O.2
Tyden, G.3
-
81
-
-
0036167883
-
Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans
-
Bekersky, I., Fieldiny, R.M., Dressler, D.E., Lee, J.W., Buell, D.N., Walsh, T.J. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother 2002, 46: 828-33.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 828-833
-
-
Bekersky, I.1
Fieldiny, R.M.2
Dressler, D.E.3
Lee, J.W.4
Buell, D.N.5
Walsh, T.J.6
-
82
-
-
0025816499
-
Comparative safety, tolerance and pharmacokinetics of amphotericin B lipid complex and amphotericin B deoxycholate in healthy male volunteers
-
Kan, V.L., Bennett, L.E., Amantea, M.A. et al. Comparative safety, tolerance and pharmacokinetics of amphotericin B lipid complex and amphotericin B deoxycholate in healthy male volunteers. J Infect Dis 1991, 164: 418-25.
-
(1991)
J Infect Dis
, vol.164
, pp. 418-425
-
-
Kan, V.L.1
Bennett, L.E.2
Amantea, M.A.3
-
83
-
-
0026002361
-
Tissue distribution of amphotericin B lipid complex in laboratory animals
-
Olsen, S.J., Swerdel, M.R., Blue, B., Clark, J.M., Bonner, D.P. Tissue distribution of amphotericin B lipid complex in laboratory animals. J Pharm Pharmacol 1991, 43: 831-5.
-
(1991)
J Pharm Pharmacol
, vol.43
, pp. 831-835
-
-
Olsen, S.J.1
Swerdel, M.R.2
Blue, B.3
Clark, J.M.4
Bonner, D.P.5
-
84
-
-
0029828007
-
Amphotericin B lipid complex: Review of safety, pharmacokinetic and efficacy
-
Dix, S.P., Wingard, J.R. Amphotericin B lipid complex: Review of safety, pharmacokinetic and efficacy. Drugs Today 1996, 32 (Suppl. G): 19-25.
-
(1996)
Drugs Today
, vol.32
, Issue.SUPPL. G
, pp. 19-25
-
-
Dix, S.P.1
Wingard, J.R.2
-
85
-
-
0025773798
-
Novel antifungal drug delivery: Stable amphotericin B-cholesteryl sulfate discs
-
Guo, L.S., Fielding, R., Lasic, D.D., Hamilton, R.L., Mufson, D. Novel antifungal drug delivery: Stable amphotericin B-cholesteryl sulfate discs. Int J Pharmaceutics 1991, 75: 45-54.
-
(1991)
Int J Pharmaceutics
, vol.75
, pp. 45-54
-
-
Guo, L.S.1
Fielding, R.2
Lasic, D.D.3
Hamilton, R.L.4
Mufson, D.5
-
86
-
-
0026595038
-
Relationship of pharmacokinetics and drug disribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs
-
Fielding, R., Singer, A., Wang, L., Babbar, S., Gud, L. Relationship of pharmacokinetics and drug disribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs. Antimicrob Agents Chemother 1992, 36: 299-307.
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 299-307
-
-
Fielding, R.1
Singer, A.2
Wang, L.3
Babbar, S.4
Gud, L.5
-
87
-
-
0028932001
-
Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and fungizone after repeated dosing in rats
-
Wang, L.H., Fielding, R.M., Smith, P.C., Guo, L.S. Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and fungizone after repeated dosing in rats. Pharm Res 1995, 12: 275-83.
-
(1995)
Pharm Res
, vol.12
, pp. 275-283
-
-
Wang, L.H.1
Fielding, R.M.2
Smith, P.C.3
Guo, L.S.4
-
88
-
-
0026731426
-
Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics
-
Janknegt, R., de Marie, S., Bakker-Woudenberg, J.A., Crommelin, D. Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet 1992, 23: 279-91.
-
(1992)
Clin Pharmacokinet
, vol.23
, pp. 279-291
-
-
Janknegt, R.1
De Marie, S.2
Bakker-Woudenberg, J.A.3
Crommelin, D.4
-
89
-
-
0025845362
-
Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers
-
Sanders, S.W., Buchi, K.N., Goddard, M.S., Lany, J.K., Tolman, K.G. Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers. Antimicrob Agents Chemother 1991, 35: 1029-34.
-
(1991)
Antimicrob Agents Chemother
, vol.35
, pp. 1029-1034
-
-
Sanders, S.W.1
Buchi, K.N.2
Goddard, M.S.3
Lany, J.K.4
Tolman, K.G.5
-
90
-
-
0036237750
-
In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum
-
Tsuchimori, N., Hayashi, R., Kitamoto, N. et al. In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum. Antimicrob Agents Chemother 2002, 46: 1388-93.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 1388-1393
-
-
Tsuchimori, N.1
Hayashi, R.2
Kitamoto, N.3
-
91
-
-
0036090563
-
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of candida
-
Pfaller, M.A., Messer, S.A., Hollis, R.J., Jones, R.N., Diekema, D.J. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of candida. Antimicrob Agents Chemother 2002, 46: 1723-7.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 1723-1727
-
-
Pfaller, M.A.1
Messer, S.A.2
Hollis, R.J.3
Jones, R.N.4
Diekema, D.J.5
-
92
-
-
0344837276
-
Yatakemycin, a novel antifungal antibiotic produced by Streptomyces. TP-A0356
-
Igarashi, Y., Futamata, K., Fujita, T. et al. Yatakemycin, a novel antifungal antibiotic produced by Streptomyces. TP-A0356. J Antibiot 2003, 56: 107-13.
-
(2003)
J Antibiot
, vol.56
, pp. 107-113
-
-
Igarashi, Y.1
Futamata, K.2
Fujita, T.3
-
93
-
-
0036146358
-
In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent
-
Yasuki, K., Tamako, H., Takashi, F. et al. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent. Antimicrob Agents Chemother 2002, 46: 367-70.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 367-370
-
-
Yasuki, K.1
Tamako, H.2
Takashi, F.3
|